Page last updated: 2024-10-29

imipramine and Frontotemporal Dementia

imipramine has been researched along with Frontotemporal Dementia in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Frontotemporal Dementia: The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lopez, E1
Fraile, S1
Hidalgo, FJ1
GarcĂ­a, B1

Other Studies

1 other study available for imipramine and Frontotemporal Dementia

ArticleYear
[Possible malignant neuroleptic syndrome associated with aripiprazole and imipramine and treated with bromocriptine].
    Medicina clinica, 2013, Sep-21, Volume: 141, Issue:6

    Topics: Antipsychotic Agents; Aripiprazole; Bromocriptine; Combined Modality Therapy; Drug Therapy, Combinat

2013